Target intelligence / Profile preview

Type IV pili (T4P) (T4P)

Target
T4P
Molecular classification
Surface protein complex, Bacterial appendage, Virulence factor
01

Overview

Type IV pili (T4P) are multifunctional, filamentous surface appendages that are critical for the virulence and environmental adaptation of Pseudomonas aeruginosa (1.3.1, 1.3.3). These structures are primarily composed of polymerized PilA subunits and are dynamic, undergoing cycles of extension and retraction powered by the ATPases PilB and PilT, respectively (1.2.2, 1.5.1). This dynamic action facilitates twitching motility, a form of surface-associated movement that allows the bacteria to navigate host surfaces and aggregate into microcolonies (1.1.2, 1.3.1). T4P also serve as essential adhesins, mediating the initial attachment of P. aeruginosa to host epithelial cells, which is a prerequisite for colonization and subsequent infection (1.3.1, 1.3.3). In addition to motility and adhesion, T4P play a significant role in biofilm maturation and the uptake of horizontal genetic material through natural transformation (1.3.3, 1.3.4). They also act as the primary receptors for many lytic bacteriophages, making them a focal point for phage therapy development (1.1.3, 1.3.5). Therapeutic strategies targeting T4P include monoclonal antibodies designed to inhibit adhesion or promote opsonophagocytosis, as well as small molecules that disrupt the assembly machinery (1.3.1, 1.4.1). By targeting these pili, researchers aim to reduce bacterial pathogenicity and biofilm-associated antibiotic tolerance, providing a potent anti-virulence approach against multidrug-resistant P. aeruginosa strains (1.3.1, 1.3.4).

Other names
Type 4 piliT4PFimbriaeTwitching motility apparatusPilA complexType IVa pili
02

Mechanism of action

Inhibition of pilus assembly and retraction, blocking of bacterial adhesion to host tissues, and facilitation of lytic bacterial destruction through phage-mediated entry (1.3.1, 1.3.5, 1.4.1).

03

Biological functions

Twitching motilityBacterial adhesionBiofilm formationDNA uptakePhage infection receptorImmune evasion
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsisKeratitis
05

Safety considerations

Development of phage resistance through PilA mutationsPotential compensatory upregulation of non-pilus adhesins like OprHHigh sequence variability of PilA across different clinical strains
06

Interacting drugs

Anti-QA monoclonal antibody (1.4.1)

5 more in the full profile.

07

Biomarkers

PilA expression levelsTwitching motility phenotypePilA glycosylation status

Beyond the preview

Go deeper on Type IV pili (T4P) (T4P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type IV pili (T4P) (T4P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call